Medicinal Product Shortages - update - 22 March 2023

Notice type: Advisory

Date: 22/03/2023

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

.

Product

Active Ingredient(s)

Atozet 10mg/40mg Film Coated Tablets

PA23198/022/003

Organon Pharma (Ireland) Limited

Ezetimibe & atorvastatin

Augmentin Duo Mixed Fruit 400 mg/57mg/5ml Powder for Oral Suspension

(35 ml presentation)

PA1077/019/006

GlaxoSmithKline (Ireland) Limited

Amoxicillin & clavulanic acid

Calcichew 500mg Chewable Tablets

PA2239/013/001

CHEPLAPHARM Arzneimittel GmbH

Calcium carbonate

Calvepen 333mg Tablets

PA0126/137/001

Clonmel Healthcare Ltd

Phenoxymethylpenicillin

Calvepen 250mg/5ml Powder for Oral Suspension

PA0126/137/003

Clonmel Healthcare Ltd

Phenoxymethylpenicillin

Clonocid 250mg Film Coated Tablets

PA0126/136/001

Clonmel Healthcare Ltd

Clarithromycin

Clonocid 500mg Film Coated Tablets

PA0126/136/002

Clonmel Healthcare Ltd

Clarithromycin

Emtricitabine/Tenofovir disoproxil Accordpharma 200mg/245mg Film Coated Tablets

PA2315/200/002

Accord Healthcare Ireland Ltd.

Emtricitabine & tenofovir disoproxil

Inegy 10mg/80mg Tablets

PA23198/024/004

Organon Pharma (Ireland) Limited

Ezetimibe & simvastatin

Keflex 500mg Film Coated Tablets

PA1226/002/004

Flynn Pharma Limited

 

Cefalexin

Olmesartan 20mg Film Coated Tablets

PA0126/273/002

Clonmel Healthcare Ltd

Olmesartan


Newly notified shortages

The HPRA has been notified of a shortage of the following products:

.

Product

Active Ingredient(s)

Adenuric 80mg Film Coated Tablet

EU/1/08/447/001

Menarini International Operations Luxembourg S.A.

Febuxostat

Apidra Solostar 100units/ml Solution for Injection in a Pre-Filled Pen

EU/1/04/285/032

Sanofi-Aventis Deutschland GmbH

Insulin glulisine

Creon 25000 Gastro Resistant Capsules

PA2010/008/002

Mylan IRE Healthcare Limited

Pancreas powder

Klacid Forte 500mg Film Coated Tablets

PA2010/004/002

Mylan IRE Healthcare Limited

Clarithromycin

Lyclear 5% w/w Dermal Cream

PA1077/066/001

GlaxoSmithKline (Ireland) Limited

Permethrin

Omeprazole Pinewood 20mg Gastro Resistant Capsules

PA0281/152/001

Pinewood Laboratories Ltd

Omeprazole

Pergoveris (900 IU/450IU)/1.44 mL Solution for Injection

EU/1/07/396/006

Merck Europe B.V.

Lutropin alfa & follitropin alfa

Ritalin LA 20mg Prolonged Release Capsules

PA1972/002/002

InfectoPharm Arzneimittel und Consilium GmbH

Methylphenidate

Telmisartan/Hydrochlorothiazide Rowa 80mg/25mg Tablets

PA0074/081/003

Rowa Pharmaceuticals Limited

Telmisartan & hydrochlorothiazide

 

Telmisartan/Hydrochlorothiazide Rowa 40mg/12.5mg Tablets

PA0074/081/001

Rowa Pharmaceuticals Limited

Telmisartan & hydrochlorothiazide

Zithromax Powder for Oral Suspension 200mg/5ml

(22.5ml presentation only)

PA0822/191/002

Azithromycin


 Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

 



« Back